Today’s top gainers include the company Abbott Laboratories (NYSE:ABT) which is in the industry Medical Appliances & Equipment, gaining 1.03% today. In the last week its performance is 0.81%, and 17.11% for the past quarter. Currently, Abbott Laboratories, ABT has a target price of 47.79, so today’s gain of 1.03% is a significant step towards its target price. The GAP today is therefore 0.42%.
Abbott Laboratories (NYSE:ABT), has a market cap of 65391.24, and is based in USA. Insider ownership is at 0.30%, and institutional ownership is 71.40%.
At the current price of 45.27, it has a dividend yield of 2.32%, and its target price is 47.79. This is with a profit margin of 11.10%, and total debt/equity of *TBA. Abbott Laboratories (NYSE:ABT) has a P/E of 34.39, as well as a forward P/E of 18.27.
With a current EPS of 1.3, and a forecasted EPS growth for next year at 11.45%,Abbott Laboratories (NYSE:ABT) has had a EPS growth for the past five years at -10.30%. For the next five years EPS growth is projected to be 9.36%.
Performance for the year is -9.05%. Since its IPO date on 4/6/1983, the total performance to date is 1.64%.
Volume today for Abbott Laboratories (NYSE:ABT), is 2576669, while its average volume is 10616.32. Whilst the total gain today was 1.03%, it did have a day high of -1.14%.
Volatility for this week has been at 1.44%, and 1.36% for the month. The 52-week low for Abbott Laboratories, ABT has been 27.30%, while the 52-week-high has reached -9.35%.
Looking at its return of investments, which is 7.70%, and its return on assets is *TBA. Abbott Laboratories (NYSE:ABT) has an operating margin of 14.00%. With a sales growth of 3.20% quarter over quarter. Bearing in mind that Abbott Laboratories, ABT is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.
So what is the value of Abbott Laboratories? Well its PEG is 3.67, and the P/S is 3.18, along with a P/B of 3.18. Meanwhile it has a p/cash of *TBA.